Attend the FierceBiotech Executive Breakfast at JP Morgan
Joni us on January 8th at the Fairmont in San Francisco. Reserve your seat today.
The new team brings together the CRO’s existing expertise in flow cytometry, immunoassays, cell-based assays and immunotoxicology.
Atomwise is the first company to commercialize deep neural networks for drug discovery.
A CAR-T biotech formed by Juno and WuXi got off a $90 million series A with Chinese backing, as it eyes clinical trials of its new cancer therapy.
Sanofi will license out a host of infectious disease assets to Evotec, with 100 staffers also moving into its R&D engine.
Big Pharma Novartis is teaming up with virtual clinical trial company Science 37 to boost the Swiss major’s ability to run “site-less” studies.
As biopharmas struggle to recruit patients for clinical trials, PPD and Acurian are hoping to make the process easier with a new “concierge service.”
The acquisition creates the first AI company to be able to work on the entire drug discovery and development process, says BenevolentAI.
British-based oncology R&D charity Cancer Research UK will inject £45 million ($63 million) across its clinical trial network in the U.K.
The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.
Preclinical CRO Sinclair Research has carved out a new role for G. Alex Wakefield as he becomes its vice president of research and operations.